Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$18.1M Buy
98,100
+40,000
+69% +$7.08M 0.08% 248
2018
Q1
$9.9M Buy
58,100
+14,500
+33% +$2.66M 0.04% 456
2017
Q4
$7.58M Sell
43,600
-23,700
-35% -$4.19M 0.04% 607
2017
Q3
$12.5M Sell
67,300
-46,900
-41% -$8.31M 0.06% 318
2017
Q2
$19.7M Sell
114,200
-14,500
-11% -$2.36M 0.11% 163
2017
Q1
$21.1M Buy
128,700
+500
+0.4% +$83.1K 0.17% 114
2016
Q4
$18.7M Sell
128,200
-96,800
-43% -$14.6M 0.13% 144
2016
Q3
$37.5M Buy
225,000
+106,900
+91% +$18.1M 0.28% 41
2016
Q2
$18M Buy
118,100
+8,300
+8% +$1.29M 0.14% 139
2016
Q1
$16.5M Sell
109,800
-44,900
-29% -$6.67M 0.13% 158
2015
Q4
$25.1M Sell
154,700
-57,400
-27% -$9.02M 0.17% 105
2015
Q3
$29.3M Buy
212,100
+94,600
+81% +$14.9M 0.15% 122
2015
Q2
$18M Sell
117,500
-59,500
-34% -$9.53M 0.11% 210
2015
Q1
$28.3M Sell
177,000
-31,000
-15% -$4.88M 0.22% 64
2014
Q4
$33.1M Buy
208,000
+151,700
+269% +$23.6M 0.25% 52
2014
Q3
$7.91M Buy
56,300
+7,400
+15% +$966K 0.06% 406
2014
Q2
$5.79M Sell
48,900
-94,300
-66% -$10.9M 0.06% 451
2014
Q1
$17.7M Buy
143,200
+61,800
+76% +$7.5M 0.15% 109
2013
Q4
$9.29M Sell
81,400
-209,400
-72% -$23.8M 0.06% 363
2013
Q3
$16.3M Buy
290,800
+169,400
+140% +$18.4M 0.11% 159
2013
Q2
$12K Buy
+121,400
New +$12.6M 0.05% 243

Other funds holding AMGN

PEAK6 Group's AMGN Position: Q2 2018 in Review

PEAK6 Group increased its Amgen (AMGN) stake by 4.5% in Q2 2018, buying an estimated $83K and bringing the position to 10,886 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #1357.

PEAK6 Group first reported a position in AMGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $12.2M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • PEAK6 Group held 10,886 shares of Amgen worth $2.01M as of Q2 2018.
  • PEAK6 Group bought 469 Amgen shares in Q2 2018, an estimated $83K.
  • Amgen made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1357 holding.
  • PEAK6 Group first reported a position in Amgen in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Amgen position peaked at $12.2M in Q3 2016.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.